Back to results
US 2021/0059964 A1Published application
Anti-I-Type Allergy Agent, Degranulation Inhibitor for Basophils and Mast Cells, Anti-Dementia Agent, Agent for Improving/Inhibiting Short-Term Memory Impairment
AssigneeMitsui Sugar Co., Ltd.
InventorsToma Furuta, Masami Mizu
Life of this patent
Estimating the term…
Abstract
According to an aspect of the present invention, there is provided an anti-I-type allergy agent including: p-coumaric acid as an active ingredient. In addition, according to another aspect of the present invention, there is provided an anti-dementia agent including: p-coumaric acid as an active ingredient.
Claims12
1-5. (canceled)
A method for inhibiting type I allergies comprising:
- administering an effective amount of an agent comprising p-coumaric acid to a subject in need thereof.
A method for inhibiting degranulation of basophils and mast cells comprising:
- administering an effective amount of a degranulation inhibitor for basophils and mast cells comprising p-coumaric acid to a subject in need thereof.
A method for improving/inhibiting dementia or short-term memory impairment comprising:
- administering an effective amount of an agent comprising p-coumaric acid as to a subject in need thereof.
Dependencies are inferred from the claim text.